WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1996007427) CAPSULAR POLYSACCHARIDE IMMUNOMODULATOR
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1996/007427    International Application No.:    PCT/US1995/011160
Publication Date: 14.03.1996 International Filing Date: 01.09.1995
Chapter 2 Demand Filed:    02.04.1996    
IPC:
A61K 39/114 (2006.01)
Applicants: BRIGHAM AND WOMEN'S HOSPITAL, INC. [US/US]; 75 Francis Street, Boston, MA 02115 (US)
Inventors: TZIANABOS, Arthur, O.; (US).
ONDERDONK, Andrew, B.; (US).
KASPER, Dennis, L.; (US)
Agent: GATES, Edward, R.; Wolf, Greenfield & Sacks, P.C., 600 Atlantic Avenue, Boston, MA 02210 (US)
Priority Data:
08/301,271 02.09.1994 US
08/502,865 14.07.1995 US
Title (EN) CAPSULAR POLYSACCHARIDE IMMUNOMODULATOR
(FR) IMMUNOMODULATEUR POLYSACCHARIDIQUE CAPSULAIRE
Abstract: front page image
(EN)Methods and products for protecting against abscess formation associated with surgery, trauma or diseases that predispose the host to abscess formation are provided. Methods for forming immunomodulators and pharmaceutical compositions relating thereto are also provided. The products useful in the invention are polysaccharides including a repeat unit having a positively charged free amino group and a negatively charged group. The preferred polysaccharide is $i(B. fragilis) capsular polysaccharide A.
(FR)L'invention concerne des procédés et des produits destinés à protéger contre la formation d'abcès associée à la chirurgie, aux traumatismes ou aux maladies qui prédisposent l'hôte à la formation d'abcès. L'invention concerne également des procédés pour former des immunomodulateurs et des compositions pharmaceutiques s'y rapportant. Les produits utiles dans l'invention sont des polysaccharides renfermant un motif récurrent possédant un groupe amino libre à charge positive et un groupe à charge négative. Le polysaccharide préféré est le polysaccharide A capsulaire $i(B. fragilis).
Designated States: AM, AT, AU, BB, BG, BR, BY, CA, CH, CN, CZ, DE, DK, EE, ES, FI, GB, GE, HU, IS, JP, KE, KG, KP, KR, KZ, LK, LR, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, TJ, TM, TT, UA, UG, UZ, VN.
African Regional Intellectual Property Organization (KE, MW, SD, SZ, UG)
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)